The Wall Street Journal, November 15, 2017

Cardinal Health Inc. has agreed to sell its Chinese pharmaceutical and medical-products distribution business to a local rival, in the latest pullback by a U.S. company in the world’s second-largest economy.

Facebook icon
LinkedIn icon
Twitter icon